For decades, population-based reference ranges have been the default benchmark for clinical decision-making. But traditional reference intervals are built to detect overt disease—not to define optimal health. 

In this webinar, Mark L. Gordon, MD, challenges the limitations of population averages and presents a precision physiology framework for laboratory interpretation. Using key neuroendocrine biomarkers—including free testosterone—he demonstrates how to move beyond static thresholds and identify functional decline years before pathology develops. 

What You’ll Take Away

 In this session, we shift the diagnostic focus from reactive disease detection to proactive, outcome-based medicine. 

You'll learn:

• Why "Normal" Doesn't Mean Healthy: How standard reference ranges can overlook cellular and receptor-level insufficiency, even when serum levels appear optimal. 

• How Insufficiency Precedes Disease: Strategies to identify early biochemical decline in hormones and neurosteroids before irreversible pathology occurs. 

• The Power of Precision Physiology: How to use longitudinal biomarker tracking, multi-cluster panels, and individualized baselines to optimize patient performance, energy, and cognitive resilience.